Groundbreaking treatment enhances the immune system’s ability to fight cancer Holy Cross Health now offers bispecific therapy, an innovative class of antibody drugs providing new hope for patients ...

In a perspective, Northwestern Engineering’s Chad Mirkin and Milan Mrksich argue that structural precision drives therapeutic ...

Many patent applicants currently face difficulty in obtaining antibody claims because of written description and enablement ...

AstraZeneca and Daiichi Sankyo are gunning to get Enhertu a new first-line approval in HER2-positive breast cancer after a ...

A team of scientists has uncovered the remarkable potential of a human antibody, mAb 3A6, in fighting Ebola virus infections.